Patent · US Active

Polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide

US9079881B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

Vantia Limited · GB

Inventors

Kjellström Henrik Johan · Copenhagen, DK
Johansson Erik Björn · Malmö, SE
Vilhelmsen Thomas · Greve Strand, DK

Key dates

Filing date	Mar 31, 2011
Grant date	Jul 14, 2015
Priority date	—
Expiry date	Jan 22, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a new polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzyl-carbamoyl)-L-proline-N,N-dimethylamide, pharmaceutical compositions containing it and its use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.